# A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults

> **NCT06633562** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Lohocla Research Corporation** · enrollment: 32 (estimated)

## Conditions studied

- Healthy
- Safety Evaluation of Escalating Doses
- Tolerability

## Interventions

- **DRUG:** Nezavist SDD
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06633562
- **Lead sponsor:** Lohocla Research Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-02-28
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06633562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06633562, "A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT06633562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*